dabrafenib

Ukraine

Drugs containing this active substance

  • TAFINLAR®

    The drug is prescribed to adults for the treatment of unresectable or metastatic melanoma (provided the BRAF V600 mutation is present), as well as for adjuvant therapy of stage III melanoma and the treatment of advanced non-small cell lung cancer (provided the BRAF V600 mutation is present).

    Form: capsules, hard

    Active substance Dosage
    dabrafenib 50 mg

    ATC: L01EC02

    Manufacturer: Glaxo Operations UK Limited (manufacturer of unpackaged products)

  • TAFINLAR®

    The drug is indicated for adults for the treatment of unresectable or metastatic melanoma (provided the BRAF V600 mutation is present), as well as for adjuvant therapy of stage III melanoma and the treatment of advanced non-small cell lung cancer (provided the BRAF V600 mutation is present).

    Form: capsules, hard

    Active substance Dosage
    dabrafenib 75 mg

    ATC: L01EC02

    Manufacturer: Glaxo Operations UK Limited (manufacturer of unpackaged products)